RE: Rns out29 May 2026 07:33
"Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION®, a tumor-activated oncology delivery platform, today announced that Richard Hughes,"
Did anyone els'e heart skip a beat when they read up to this point in the RNS, thinking Hughes might have quit?